Cyber Sport's Orbita Mouse doesn't want to be just another regular, boring mouse -- and its newness goes way beyond looks. We don't review too many mice around these parts, but this one seemed to call ...

For a study with a mere 200 patients and relatively short follow-up, the ORBITA trial has punched well beyond its weight, sparking debate among interventional and general cardiologists alike about the ...

PARIS, France—Invasive physiology tests used in the ORBITA trial did not predict which patients would benefit from PCI more than placebo in terms of the trial’s primary endpoint of improvement in ...

Philips has spent the better part of the last year racking up partnerships and acquisitions focused on improving remote healthcare options and the patient experience—and it’s showing no sign of ...

We've seen the Cyber Sport Orbita Mouse bouncing around the Internets for about a year in search of a manufacturer. Now they've got it, with a corresponding January 2009 retail delivery date to match.

Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...

BOSTON--(BUSINESS WIRE)--Orbita, the leading provider of smart virtual assistants and workflow automation for healthcare, has acquired the assets of Wellbe, a digital health company providing patient ...

February 23, 2009 The design of the trusty mouse has come a long way from its humble beginnings forty years ago and throughout its many incarnations it has remained a staple for any personal computer ...

Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PCI improved angina symptoms at 12 weeks vs. a sham ...

PARIS — New findings from the controversial ORBITA trial provide a lift for percutaneous coronary intervention (PCI) in stable angina but also mixed results for the predictive power of fractional flow ...